Arnold and colleagues designed a chimeric DNA-FANA ASO directed against downregulated in renal carcinoma (DRR)/FAM107A, which is a gene that is highly expressed in invasive glioblastoma stem cells (GSCs) and promotes GSC invasion. Here, FAM107A is linked to glioblastoma.